Investment analysts at StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a note issued to investors on Thursday. The firm set a “sell” rating on the medical technology company’s stock.
BIOLASE Price Performance
BIOL opened at $0.15 on Thursday. The company has a 50-day moving average of $0.17 and a 200-day moving average of $0.89. The company has a market capitalization of $4.78 million, a P/E ratio of 0.00 and a beta of 0.67. BIOLASE has a 1-year low of $0.13 and a 1-year high of $47.10. The company has a debt-to-equity ratio of 34.06, a quick ratio of 0.68 and a current ratio of 1.26.
BIOLASE (NASDAQ:BIOL – Get Free Report) last released its earnings results on Thursday, March 21st. The medical technology company reported ($1.76) earnings per share for the quarter. The company had revenue of $13.49 million during the quarter. BIOLASE had a negative return on equity of 555.22% and a negative net margin of 41.97%.
Institutional Investors Weigh In On BIOLASE
BIOLASE Company Profile
BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.
Featured Stories
- Five stocks we like better than BIOLASE
- What is a Death Cross in Stocks?
- United Airlines Soars on Earnings Beat
- Utilities Stocks Explained – How and Why to Invest in Utilities
- J.B. Hunt Hits the Skids: Lower Prices to Come
- How to Invest in the Best Canadian Stocks
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.